Transplantation in autoimmune liver diseases

作     者：Marcus Mottershead James Neuberger 

作者机构：Liver UnitQueen Elizabeth HospitalBirmingham B15 2THUnited Kingdom 

出 版 物：《World Journal of Gastroenterology》 (世界胃肠病学杂志（英文版）)

年 卷 期：2008年第14卷第21期

页      面：3388-3395页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：Liver transplantation Autoimmune disease Recurrence Immunosuppression 

摘      要：Liver transplantation remains an effective treatment for those with end-stage disease and with intractable liver-related *** shortage of organs for transplantation has resulted in the need for rationing.A variety of approaches to selection and allocation have been developed and vary from country to *** shortage of donors has meant that new approaches have to be adopted to make maximal use of the available organs;these include splitting grafts,use of extended criteria livers,livers from non-heart-beating donors and from living *** transplantation,most patients will need life-long immunosuppression,although a small proportion can have immunosuppression successfully *** immunosuppressive drugs and different strategies may allow a more targeted approach with a reduction in side-effects and so improve the patient and graft *** autoimmune diseases,transplantation is associated with significant improvement in the quality and length of *** may recur after transplantation and may affect patient and graft survival.